Trial intelligence / Profile preview

Cholecalciferol for RLS in CKD

NCT03063190Phase 4Withdrawn

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Mar 2022
Primary completion
Mar 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of vitamin d in restless legs syndrome (RLS), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Planned start Mar 2022; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on NCT03063190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03063190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call